{"text": "bmy bull sweeper opens some 2025 leaps"}
{"text": "mizuho high valuation of targeted therapy companies m amp a throughout the years bmy aveo mrk loxo abbv aria amgn"}
{"text": "a new quarter is nearly upon us and the first of the three q2 catalyst stories is here the team has looked at the upcoming data reveals for all the key players big and small feat lly mrk azn nvo dsnky rhhby jnj pfe bmy"}
{"text": "bmy bristol myers announces three year follow up results from the phase 3 checkmate 816 trial demonstrating"}
{"text": "bmy bristol myers squibb neoadjuvant opdivo nivolumab with chemotherapy demonstrates long term durable clinical benefits for patients with resectable non small cell lung cancer at three years in the checkmate 816 trial"}
{"text": "my thoughts nvda cost msft aapl amd lrcx bmy gild meta nflx"}
